[1]
“Apolipoprotein B in the Risk Assessment, Diagnosis, and Treatment of Cardiometabolic Diseases”, ccm, vol. 9, no. 5, pp. 427–438, Sep. 2025, Accessed: Sep. 18, 2026. Available: https://fortunejournals.org/ojs/index.php/ccm/article/view/16644